The primary side effects of liraglutide are gastrointestinal, including nausea, diarrhea, constipation, and vomiting, mitigated by gradual dose escalation
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved for type 2 diabetes (T2D), and some are also indicated for reduction of the risk of atherosclerotic CVD in T2D and for weight management
Backed by science: developed in line with the latest findings on GLP-1 function and appetite control
If you are ineligible for one of our Plans, we offer alternative Wellness Plans to help you manage and lose weight
However, given the frequent co-occurrence of the omitted conditions and those included in this analysis, the number and share excluded may be small
After starting GLP-1 injections, she noticed something different